Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects-Reference-Cited by-同舟云学术

Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects

Published:2022-02 Issue:2 Volume:27 Page:436-455
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Mirzaei Sepideh,Gholami Mohammad Hossein,Hashemi Farid,Zabolian Amirhossein,Farahani Mahdi Vasheghani,Hushmandi Kiavash,Zarrabi Ali,Goldman Aaron,Ashrafizadeh Milad,Orive Gorka

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference283 articles.

1. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update;Dong;Drug Resist Updates,2020

2. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer;Perez;Cancer,1993

3. Recent advances in the development of indazole-based anticancer agents;Dong;ChemMedChem,2018

4. Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-naïve, high-risk prostate cancer;Jaratlerdsiri;Cancer Res,2018

5. MDM2-NFAT1 dual inhibitor, MA242: effective against hepatocellular carcinoma, independent of p53;Wang;Cancer Lett,2019

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm;Biomaterials;2025-03

2. RNA editing enzyme ADAR2 regulates P-glycoprotein expression in murine breast cancer cells through the circRNA-miRNA pathway;Biochemical and Biophysical Research Communications;2024-09

3. Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling;Cell Biochemistry and Biophysics;2024-08-07

4. Sonodynamic Treatment Triggers Cancer Cell Killing by Doxorubicin in P‐Glycoprotein‐Mediated Multidrug Resistant Cancer Models;Advanced Therapeutics;2024-08-03

5. Novel N,N-Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant Cells;Journal of Medicinal Chemistry;2024-08-01